DalsnaFinance › IPOs › Aardvark Therapeutics Inc › IPO
Aardvark Therapeutics, Inc. completed its initial public offering on NASDAQ on February 13, 2025, pricing at $16.00 a share.
| Ticker | AARD |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 13, 2025 |
| Offering price | $16.00 |
| Shares offered | 5,888,000 |
| Total raised | $94M |
Aardvark Therapeutics, Inc. sold 5,888,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $94.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $94 million total recorded for the deal.
Measured by money raised, Aardvark Therapeutics, Inc. was the 355th largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is the 258th largest.
February 2025 saw 20 completed IPOs in the site's data; by amount raised, Aardvark Therapeutics, Inc. was the 13th largest of the 20 deals with a recorded size.
Its $16.00 offer price was tied for the 109th highest (level with 11 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Aardvark Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Aardvark Therapeutics, Inc.. This page is general information, not investment advice.